.png)
.png)
A wise man said that “Perseverance is not a long race; it is many short races one after the other.”
Over the last eighteen months, we have won many of these short races together as we have adapted to the changing landscape driven by the pandemic. In this session we will hear from regulatory and industry leaders on those races; the practical challenges we have overcome from the simple to the complex, the transformative level of collaboration we have seen internally and externally, the innovation that we have accelerated and the changes that will enable us to emerge stronger.
Valerie Whelan
Vice President, Quality
Thermo Fisher Scientific
Ballycoolin, Dublin, Ireland
Melissa S. Seymour, MBA
Chief Quality Officer
Biogen
Raleigh, North Carolina, United States
Ashley B. Boam, MSBE
Director, Office of Policy for Pharmaceutical Quality, OPQ, CDER
U.S. FDA
Silver Spring, Maryland, United States
CDR Emily T. Thakur, RPh
Team Leader, CDER
U.S. FDA
Silver Spring, Maryland, United States